Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 657.80

+1.6%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: cl who wrote (109)	6/9/1997 2:52:00 AM
From: Miljenko Zuanic	of 3557

Hi CL! How are things at University? Yes, you maybe right. But, Dr. Lindsay leaving I will not connect with NT-3. It is more "cleaning the house from AMGN influence" and putting Dr. Yancopoulo in charge of all R&D (which is IMO move of the year). NT-3 show some toxicity in PI and there are probability that it will show more side effects in large trials-PII. Regn is moving more to non-cns targets which is good. mz

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next